small biotech is always a risky game, but at least FAK inhibitors have already been shown elsewhere to be efficacious in clinical trials:
FAK-targeted and combination therapies for the treatment of cancer: an overview of phase I and II clinical trials
https://www.tandfonline.com/doi/abs/10.1080/13543784.2020.1740680?journalCode=ieid20
"The FAK inhibitors examined in clinical trials thus far have been shown to have manageable toxicity profiles and have demonstrated cytostatic effects as single agents, extending progression-free survival without producing a clinical or radiographic response. Trials are currently underway to strengthen the efficacy of treatment by combining FAK inhibitors with cytotoxic chemotherapy, targeted therapy, or immunotherapy. "
and with the current atx market cap, seems almost nothing is priced in here
small biotech is always a risky game, but at least FAK...
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.4¢ |
Change
-0.001(1.54%) |
Mkt cap ! $17.38M | |||
| Open | High | Low | Value | Volume |
| 6.7¢ | 6.7¢ | 6.0¢ | $21.97K | 348.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 71825 | 6.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.5¢ | 43145 | 2 |
View Market Depth
| Last trade - 15.58pm 27/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.3¢ |
Change
-0.001 ( 4.55 %) |
||||
| Open | High | Low | Volume | ||
| 6.7¢ | 6.7¢ | 6.1¢ | 105098 | ||
| Last updated 11.28am 27/05/2024 ? | |||||
| ATX (ASX) Chart |